Concepedia

Author

Pernilla Johansson

AstraZeneca (Sweden)

Also Known As

P. Johansson, Pernilla Johansson

8

Publications

258

Citations

6

H-Index

22

Concepts

All Affiliations

AstraZeneca (Sweden)Uppsala UniversityJohannes Gutenberg University MainzSanofi (France)AbbVie (Germany)
PJ

About

Pernilla Johansson is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacokinetic modeling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

230

2

Pharmacology

5

5

230

3

Biostatistics

2

2

111

4

Gastroenterology

2

2

85

5

Biochemistry

1

1

45

Pernilla Johansson

×

5

Publications

230

Citations

5

H-Index

YearCitations

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results

Alison Margolskee, Adam S. Darwich, Xavier Pépin,

European Journal of Pharmaceutical Sciences

2016

66

The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs

David Dahlgren, Christian Roos, Pernilla Johansson,

International Journal of Pharmaceutics

2018

50

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes

Adam S. Darwich, Alison Margolskee, Xavier Pépin,

European Journal of Pharmaceutical Sciences

2016

45

Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms

David Dahlgren, Carl Roos, Pernilla Johansson,

Molecular Pharmaceutics

2016

35

Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?

Linda C. Alskär, Albin Parrow, Janneke Keemink,

Journal of Controlled Release

2019

34

Page 1